CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results

Go back to CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
(NASDAQ: CRSP) Delayed: 58.33 +1.77 (3.13%)
Previous Close $56.56    52 Week High $18.88 
Open $57.98    52 Week Low $13.75 
Day High $59.24    P/E N/A 
Day Low $56.87    EPS $0.00 
Volume 1,814,120